Seoul to procure enough COVID-19 vaccines for North, South Korea

South Korea is preparing to secure more COVID-19 vaccines via technology transfer from U.S. manufacturers Novavax Inc. and Moderna, allowing the country to produce local doses and enough potential vaccines for North and South Korea. South Korean President Moon Jae-in said Wednesday during a visit to a SK Bioscience Co. plant in Andong, North Gyeongsang Province, that Novavax vaccines will be produced in Korea and that enough vaccines to inoculate 10 million people will be secured through this supply agreement, Hankook Ilbo an and Yonhap reported.